Earnings Feed
Start Free
Home/Filings/4/0001209191-17-044359
4//SEC Filing

bluebird bio, Inc. 4

Accession 0001209191-17-044359

CIK 0001293971operating
View on SEC.govCompany Profile

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:03 PM ET

Size

23.5 KB

Accession

0001209191-17-044359

Insider Transaction Report

Form 4
Period: 2017-07-06
bluebird bio, Inc.BLUE
Sullivan Eric
Principal Accounting Officer
Transactions
  • Sale

    Common Stock

    2017-07-05$107.22/sh−733$78,595→ 5,674 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2017-07-05−250→ 1,000 total
    Exercise: $20.70Exp: 2023-12-02→ Common Stock (250 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-07-05−196→ 1,020 total
    Exercise: $24.47Exp: 2024-03-03→ Common Stock (196 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-07-05−201→ 6,069 total
    Exercise: $50.51Exp: 2026-03-01→ Common Stock (201 underlying)
  • Exercise/Conversion

    Common Stock

    2017-07-05$56.30/sh+2,933$165,128→ 9,987 total
  • Sale

    Common Stock

    2017-07-05$107.29/sh−3,580$384,111→ 6,407 total
  • Exercise/Conversion

    Common Stock

    2017-07-05$20.70/sh+250$5,175→ 6,657 total
  • Exercise/Conversion

    Common Stock

    2017-07-05$24.47/sh+196$4,796→ 6,853 total
  • Exercise/Conversion

    Common Stock

    2017-07-05$50.51/sh+201$10,153→ 7,054 total
  • Exercise/Conversion

    Stock Option (right to buy

    2017-07-05−2,933→ 8,802 total
    Exercise: $56.30Exp: 2026-08-01→ Common Stock (2,933 underlying)
Holdings

  • Common Stock

    (indirect: By Spouse)
    300
Footnotes (8)
  • [F1]The range in prices for the transaction reported on this line was $107.25 to $107.40. The average weighted price was $107.2936. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F3]The range in prices for the transaction reported on this line was $107.15 to $107.30. The average weighted price was $107.2242. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Equity grants held by the reporting person's spouse, who is employed by the issuer
  • [F5]This option vests over a four-year period, at a rate of twenty-five percent (25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
  • [F6]This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
  • [F7]This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017, and in 36 equal monthly installments.
  • [F8]This option vests over a four-year period, at a rate of twenty-five percent (25%) on July 4, 2017 and in 36 equal monthly installments thereafter.

Documents

1 file

Issuer

bluebird bio, Inc.

CIK 0001293971

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001293971

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:03 PM ET
Size
23.5 KB
View on SEC.gov